Section 102 Prior Art and Section 103 Obviousness: Leveraging CCPA and Early Federal Circuit Decisions
Withstanding Rejections and Attacks on Patent Validity and Patentability
Recording of a 90-minute premium CLE video webinar with Q&A
This CLE course will guide patent counsel on leveraging decisions by the Court of Customs and Patent Appeals (CCPA) and the Federal Circuit in applying Sections 102 and 103 prior art and obviousness standards. The panel will examine lessons learned through CCPA and early Federal Circuit decisions, as well as offer strategies for evaluating prior art and obviousness, handling evidence, and overcoming assertions of unpatentability.
Outline
- Assessing prior art
- Evaluating anticipation
- Evaluating obviousness
- Lessons from the CCPA and early Federal Circuit decisions
- Leveraging CCPA decisions and early Federal Circuit decisions to avoid untoward Sections 102 and 103 results
Benefits
The panel will review these and other key issues:
- How is evidence of unexpected properties by a claimed invention evaluated?
- What lessons can patent counsel draw from CCPA decisions when asessing prior art? When applying the statutory obviousness standard?
- What steps should patent counsel take going forward to avoid making the mistakes of the past?
Faculty
Arpita Bhattacharyya, Ph.D.
Partner
Finnegan Henderson Farabow Garrett & Dunner
Ms. Bhattacharyya, Ph.D., practices all aspects of patent law, including district court and ITC litigation, patent... | Read More
Ms. Bhattacharyya, Ph.D., practices all aspects of patent law, including district court and ITC litigation, patent office trials and examination, and client counseling, with an emphasis on patents related to medical devices, diagnostics, and electronic and mechanical technologies. She has been recognized as a WIPR Influential Women in IP Trailblazer.
CloseAdriana L. Burgy
Partner
Finnegan Henderson Farabow Garrett & Dunner
Ms. Burgy focuses on opinion work, client counseling, patent prosecution and management, and litigation in the... | Read More
Ms. Burgy focuses on opinion work, client counseling, patent prosecution and management, and litigation in the chemical, pharmaceutical, and biotechnology arts. She counsels her clients on a diverse range of patent issues. She assists clients on single-patent issues as well as complex matters involving multiple patents and applications requiring ongoing advice on patent portfolio strategy and development, with an eye towards litigation. From a patent prosecution perspective, she has drafted and prosecuted numerous patent applications domestically and internationally, guided and advised clients on complex procedural and legal issues surrounding clients' patent portfolios, developed and implemented strategic prosecution in support of ongoing litigation, generated strategies for maximizing investment in patent portfolios, and facilitated the identification of high-priority applications within patent portfolios.
CloseAliza G. Carrano
Partner
Finnegan Henderson Farabow Garrett & Dunner
Ms. Carrano is a registered patent attorney, focusing her practice on complex patent litigation before the U.S.... | Read More
Ms. Carrano is a registered patent attorney, focusing her practice on complex patent litigation before the U.S. district courts and the U.S. International Trade Commission (ITC). She works on litigation matters in a variety of technologies, primarily in the electrical, software, optical technology, wireless technology, business methods, and mechanical fields. Her litigation experience includes analyzing patent portfolios for assertion; formulating claim construction, infringement, and validity positions; taking and defending depositions; and trial. Before law school, she worked as a software engineer at Raytheon, where she analyzed and enhanced the baseline source code for the Deployable Ground Intercept Facility.
CloseThomas L. Irving
Partner
Finnegan Henderson Farabow Garrett & Dunner
Mr. Irving has 35 years of experience in the field of IP law. His practice includes due diligence, patent prosecution,... | Read More
Mr. Irving has 35 years of experience in the field of IP law. His practice includes due diligence, patent prosecution, reissue and reexamination, patent interferences, and counseling, including prelitigation, Orange Book listings of patents covering FDA-approved drugs, and infringement and validity analysis in the chemical fields, as well as litigation. Mr. Irving has served as lead counsel in many patent interferences.
Close